Skip to content

Clinical trials

Phase 2 Atrial Fibrillation trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2 Country / region: Hungary Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20071
20092
20131
20141
20192
20201
20211
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acesion Pharma2
AstraZeneca2
Bayer2
ARCA Biopharma, Inc.1
Advanz Pharma1
Anthos Therapeutics, Inc.1
Astellas Pharma Inc1
GlaxoSmithKline1
Omeicos Therapeutics GmbH1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation14
Stroke3
Atrial Flutter2
Cardiovascular Diseases1
Heart Failure1
Ischemic Attack, Transient1
Thromboembolism1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.